In the case where post-2020 alignment with EU medtech legislation and regulations does not happen during the UK-EU free trade agreement negotiations this year ̶ where mutual recognition is roundly rejected by the EU, and UK Prime Minister Boris Johnson acts on his promise to withdraw the UK from the EU on a no-deal basis ̶ the medtech and medicines sectors will be ready and covered, in regulatory terms.
That is the intention, at least, of efforts now underway to draft a Medicines and Medical Devices (MMD) bill. Initial...